383 related articles for article (PubMed ID: 26690136)
1. Mass Spectrometry-Based N-Glycomics of Colorectal Cancer.
Sethi MK; Fanayan S
Int J Mol Sci; 2015 Dec; 16(12):29278-304. PubMed ID: 26690136
[TBL] [Abstract][Full Text] [Related]
2. Identifying N-Glycan Biomarkers in Colorectal Cancer by Mass Spectrometry.
Sethi MK; Hancock WS; Fanayan S
Acc Chem Res; 2016 Oct; 49(10):2099-2106. PubMed ID: 27653471
[TBL] [Abstract][Full Text] [Related]
3. In-depth N-glycome profiling of paired colorectal cancer and non-tumorigenic tissues reveals cancer-, stage- and EGFR-specific protein N-glycosylation.
Sethi MK; Kim H; Park CK; Baker MS; Paik YK; Packer NH; Hancock WS; Fanayan S; Thaysen-Andersen M
Glycobiology; 2015 Oct; 25(10):1064-78. PubMed ID: 26085185
[TBL] [Abstract][Full Text] [Related]
4. In-Depth Analysis of the
Wang D; Kuzyk V; Madunić K; Zhang T; Mayboroda OA; Wuhrer M; Lageveen-Kammeijer GSM
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902272
[TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer cell lines show striking diversity of their O-glycome reflecting the cellular differentiation phenotype.
Madunić K; Zhang T; Mayboroda OA; Holst S; Stavenhagen K; Jin C; Karlsson NG; Lageveen-Kammeijer GSM; Wuhrer M
Cell Mol Life Sci; 2021 Jan; 78(1):337-350. PubMed ID: 32236654
[TBL] [Abstract][Full Text] [Related]
6. N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression.
Holst S; Deuss AJ; van Pelt GW; van Vliet SJ; Garcia-Vallejo JJ; Koeleman CA; Deelder AM; Mesker WE; Tollenaar RA; Rombouts Y; Wuhrer M
Mol Cell Proteomics; 2016 Jan; 15(1):124-40. PubMed ID: 26537799
[TBL] [Abstract][Full Text] [Related]
7. Human disease glycomics: technology advances enabling protein glycosylation analysis - part 1.
Everest-Dass AV; Moh ESX; Ashwood C; Shathili AMM; Packer NH
Expert Rev Proteomics; 2018 Feb; 15(2):165-182. PubMed ID: 29285957
[TBL] [Abstract][Full Text] [Related]
8. Quantitative glycomics strategies.
Mechref Y; Hu Y; Desantos-Garcia JL; Hussein A; Tang H
Mol Cell Proteomics; 2013 Apr; 12(4):874-84. PubMed ID: 23325767
[TBL] [Abstract][Full Text] [Related]
9. What Can N-glycomics and N-glycoproteomics of Cerebrospinal Fluid Tell Us about Alzheimer Disease?
Gaunitz S; Tjernberg LO; Schedin-Weiss S
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34207636
[TBL] [Abstract][Full Text] [Related]
10. Differential N-Glycosylation Patterns in Lung Adenocarcinoma Tissue.
Ruhaak LR; Taylor SL; Stroble C; Nguyen UT; Parker EA; Song T; Lebrilla CB; Rom WN; Pass H; Kim K; Kelly K; Miyamoto S
J Proteome Res; 2015 Nov; 14(11):4538-49. PubMed ID: 26322380
[TBL] [Abstract][Full Text] [Related]
11. Developments in the identification of glycan biomarkers for the detection of cancer.
Ruhaak LR; Miyamoto S; Lebrilla CB
Mol Cell Proteomics; 2013 Apr; 12(4):846-55. PubMed ID: 23365456
[TBL] [Abstract][Full Text] [Related]
12. Altered glycosylation in cancer: A promising target for biomarkers and therapeutics.
Thomas D; Rathinavel AK; Radhakrishnan P
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188464. PubMed ID: 33157161
[TBL] [Abstract][Full Text] [Related]
13. Quantitative O-glycomics based on improvement of the one-pot method for nonreductive O-glycan release and simultaneous stable isotope labeling with 1-(d
Wang C; Zhang P; Jin W; Li L; Qiang S; Zhang Y; Huang L; Wang Z
J Proteomics; 2017 Jan; 150():18-30. PubMed ID: 27585995
[TBL] [Abstract][Full Text] [Related]
14. N-glycomic profiling of colorectal cancer according to tumor stage and location.
Holm M; Nummela P; Heiskanen A; Satomaa T; Kaprio T; Mustonen H; Ristimäki A; Haglund C
PLoS One; 2020; 15(6):e0234989. PubMed ID: 32598367
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in mass spectrometry-based glycoproteomics.
Frost DC; Li L
Adv Protein Chem Struct Biol; 2014; 95():71-123. PubMed ID: 24985770
[TBL] [Abstract][Full Text] [Related]
16. Systems Glycobiology: Integrating Glycogenomics, Glycoproteomics, Glycomics, and Other 'Omics Data Sets to Characterize Cellular Glycosylation Processes.
Bennun SV; Hizal DB; Heffner K; Can O; Zhang H; Betenbaugh MJ
J Mol Biol; 2016 Aug; 428(16):3337-3352. PubMed ID: 27423401
[TBL] [Abstract][Full Text] [Related]
17. Glycans and glycoproteins as specific biomarkers for cancer.
Kailemia MJ; Park D; Lebrilla CB
Anal Bioanal Chem; 2017 Jan; 409(2):395-410. PubMed ID: 27590322
[TBL] [Abstract][Full Text] [Related]
18. The Repertoire of Glycan Alterations and Glycoproteins in Human Cancers.
Kori M; Aydin B; Gulfidan G; Beklen H; Kelesoglu N; Caliskan Iscan A; Turanli B; Erzik C; Karademir B; Arga KY
OMICS; 2021 Mar; 25(3):139-168. PubMed ID: 33404348
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics for glycomics: status, methods, requirements and perspectives.
von der Lieth CW; Bohne-Lang A; Lohmann KK; Frank M
Brief Bioinform; 2004 Jun; 5(2):164-78. PubMed ID: 15260896
[TBL] [Abstract][Full Text] [Related]
20. The role of N-glycans in colorectal cancer progression: potential biomarkers and therapeutic applications.
de Freitas Junior JC; Morgado-Díaz JA
Oncotarget; 2016 Apr; 7(15):19395-413. PubMed ID: 26539643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
